About the Book
This is the seventh monograph in the series Progress and Controversies in Oncologic Urology (PACIOU). Containing contributions from experts from around the globe, this book provides the most up-to-date information available on the mechanisms and treatment of prostate cancer and male sexual dysfunction. Highlighting the relationship between research
Table of Contents:
SEXUAL FUNCTION: MECHANISMS AND TREATMENT Sexual Health of the Aging Male, E.J.H. Meuleman Determinants of Sexual Function in the Aging Male, J.L.H.R. Bosch The Impact of Radical Prostatectomy and Primary Radiotherapy for Localized Prostate Cancer on Quality of Life, M.L. Essink-Bot, I.J. Korfage, H.J. de Koning Sexual Function Before and After Radical Retropubic Prostatectomy: A Prospective Analysis, G.R. Dohle, Y.D. Dubbelman, S.F.M. Broersen, M. Wildhagen and F.H. Schroder Effects of Endocrine Treatment - Can Libido and Sexual Function be Preserved? P. Iversen Oral Therapy, H. Porst Intracavernosal Injection Therapy for Erectile Dysfunction: An Update, F. Montorsi Mechanisms and Prevention of Erectile Dysfunction after Radiotherapy for Prostate Cancer, L. Incrocci BENIGN PROSTATE HYPERPLASIA: PROGRESS AND CONTROVERSY IN DIAGNOSIS AND THERAPY Evaluation and Management of Lower Urinary Tract Symptoms Related to Benign Prostate Disease: The Contribution of the International Continence Society (ICS)- 'Benign Prostatic Hyperplasia' Study, J.L. Donovan Distinguishing Nocturnal Polyuria from Benign Prostatic Hyperplasia-Related Nocturnia: Simple Algorithms for General and Urological Practice, M.H. Blanker and J. Prins Practical Application of Non-Invasive Tests to Grade Outflow Obstruction and Bladder Contractility: The End of Classical Urodynamics? J.J.M. Pel, J.W.M.C. Huang Foen Chung, and R. van Mastrigt Screening for Prostate Cancer within the Benign Prostatic Hypertrophy Population: Current Evidence and Future Directions, M.R. Cooperberg and P.R. Carroll Androgen Supplementation in Older Men: What is the Impact on PSA, Prostate Growth, and Lower Urinary Tract Symptoms? L.J.G. Gooren and M. Bunck BASIC RESEARCH ON PROSTATE CANCER Diagnosis, Classification, and Therapy Development for Human Prostate Cancer Using Biochip Technologies and Post-Genomic Era Molecular Medicine, O.P. Kallioniemi, M. Wolf, L. Bubendorf and S. Mousses Candidate Genetic Markers and Therapeutic Targets in Hereditary and Sporadic Prostate Cancer, P. Berthon Basic Research on Prostate Cancer : Signal Transduction, Z. Culig Stem Cells and Differentiation in Human Prostate Cancer, J.R. Masters, T.N. Alam, C.L. Foley, I. Laczko and D.L. Hudson Role of the Stromal Micro Environment in Carcinogenesis of the Prostate, G.R. Cunha, S.W. Hayward, Y.Z. Wang and W.A. Ricke Prostate Cancer Xenograft Models, J.C. Romijn Hormonal Regulation of Prostate Cancer, C.A. Berrvoets, A. Umar and A.O. Brinkmann Profiling Protein Interactions in Angiogenesis, R. Pasqualini and W. Arap TRANSLATIONAL RESEARCH INPROSTATE CANCER: WHAT IS CLOSE TO CLINICAL PRACTICE The Immunotherapy of Prostate Cancer, G. Dalgleish Prognostic Tissue Factors for Prostate Cancer: Recent Developments and Pitfalls, M.A. Noordzij Diagnostic Markers for Prostate Cancer Detected in Serum, Plasma or Blood; Prostate-Specific Antigen-Forms and Human Kallikrein 2 (hK2) for Early Detection and Staging, H. Huland, A. Haese and H. Lilja Expected Impact of New Technologies on Prostate Cancer Research, G. Jenster DIAGNOSIS AND OUTCOME IN LOCALLY CONFINED PROSTATE CANCER Predictive Algorithms and their Clinical Relevance, M. Graefen and H. Huland Defining the Proper 'Window of Opportunity' in the Early Detection of Prostate Cancer, A.N. Vis Screening for Prostate Cancer: Views from the UK and the Rest of the World, F.C. Hamdy Outcome after Radical Prostatectomy - How Predictive are Biopsy versus Radical Prostatectomy Specimens? L. Boccon-Gibod, L. Nicolas, O. Dumonceau, V. Ravery, M. Toublanc, Li Boccon-Gibod PROSTATE CANCER, EPIDEMIOLOGY, RISK FACTORS, AND OUTCOMES PER TREATMENT A Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer, H. Haggman, Prostate Cancer Mortality and Screening, S. Oliver Expectant Management with Selective Delayed Intervention for Favorable Risk Prostate Cancer, L. Klotz Is Cure of Prostate Cancer Possible in those in Whom it is Necessary, P.C. Walsh RENAL CANCER Modern Molecular Classification of Renal Cell Carcinoma: Relevance for Urologists? F. Algaba Prognostic Factors for Renal Cell Carcinoma, Z. Kirkali, E. Tuzel and M. Ugur Mungan High-Tech Diagnostic Procedures in RCC: Promise and Practice, G.P. Krestin and F. Cademartiri Technical and Surgical Progress in Organ-Sparing Approaches for RCC,J. Hoang-Boam and P. Alken Surgery for Renal Cell Carcinoma: The Case for Open Surgery, D. Jacqmin Laparoscopic Partial Nephrectomy: Pro, J. Rassweiler and S.K.H. Yip Laparoscopic Radical and Nephrectomy - Pro, D. Teber, V. Moraga, S. Yip, Y. Dekel, T. Frede, O. Seeman and J. Rassweiler Clinical Research Avenues in Metastactic Renal Cell Carcinoma, G.H.J. Mickisch PROSTATE CANCER, LOCALLY ADVANCED AND NODE POSITIVE Diet and Prostate Cancer, K. Griffith, L.J. Denis and A. Turkes Determinants of Prostate Cancer-Specific Survival Following Radiation Therapy for Patients with Clinically Localized Prostate Cancer, A.V. D'Amico Use of Adjuvant Hormonal Therapy with Radical Prostatectomy in N+ Disease: Rationale and Contribution to Outcome, R.P Myers, E.J. Bergstralh, J.M. Slezak, G.M. Farrow, M.M. Lieber, M.L. Blute and H. Zincke ADVANCED PROSTATE CANCER Side Effects of Endocrine Treatment: Role of Duration of Treatment, D. Kirk Chemotherapy for the Treatment of Hormone-Refractory Prostate Cancer: Evaluating New Targets Based on Apoptotic Pathways, D.P. Petrylak The Role of Biphosphonates in Prostatic Cancer, D.S. Ernst Direct from the Pipeline: Results of Phase I and II Studies of New Drugs, C. Sternberg Chemotherapy in the Management of Prostate Cancer, C. Logothetis and R.E. Millikan
